Contact Supplier

Contact Supplier

To get in touch with Bachem AG, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .

    Bachem at Swiss RNA Therapeutics Summit

    news-releasesBachem AG
    January 9th 2025

    Bubendorf, Switzerland: – Peptide and oligonucleotide technology manufacturers Bachem AG will be a high-profile presence at the 3rd Swiss RNA Therapeutics Summit in Bern.

    The one-day knowledge-sharing conference with an associated workshop will mark Bachem’s first European event of the 2025 calendar.

    Genetic therapies

    First hosted in 2023, the annual Swiss RNA Therapeutics Summit aims to advance the science of genetics-based medicine by bringing together key stakeholders in the field, including academia, biotech and pharma companies, manufacturing organisations, government, and regulatory bodies.

    Bachem will be represented at the 2025 conference by two senior Business Development Managers, Dr. Daniel Bachmann and Dr. Mathias Beysard.

    About Bachem

    Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has more than 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

    Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

    For further information, see www.bachem.com

    About Swiss RNA Therapeutics Summit 2025

    The 3rd Swiss RNA Therapeutics Summit will be a one-day event on Thursday, January 23, 2025, staged at the UniS building of the University of Bern.

    The program will consist of keynotes, panel discussions and presentations, as well as a poster session and networking opportunities during the lunch break.

    The event is organised by the Swiss National Center of Competence in Research in RNA & Disease (NCCR RNA & Disease) based in the University of Bern and ETH Zürich with funding from the Swiss National Science Foundation. Further details at: https://rnatx.ch

    Resources

    Click on Bachem January 2025 Events for further information.
    Click on Bachems News to see latest News & Events.

    TRENDING ARTICLE

    Maintaining Resilient TIDES Supply in a VUCA World

    FREE DOWNLOAD
    Bachem at Swiss RNA Therapeutics Summit
    Bachem at Swiss RNA Therapeutics Summit

    Dr. Daniel Bachmann, Business Development Manager, Bachem AG.

    Bachem at Swiss RNA Therapeutics Summit

    Dr. Mathias Beysard, Business Development Manager, Bachem AG.

    Bachem AG

    Contact Information
    Address: Hauptstrasse 144, 4416, Bubendorf, Switzerland
    Telephone No: +41 58 595 2021

    Contact Bachem AG

    Simply fill out the form below to contact Bachem AG now.

    Send Bachem AG a Message